Demonising Justin Gatlin
13th September 2015
The Canadian Centre for Ethics in Sport (CCES) announced today that Vincent Figliomeni, a U Sports hockey player from Ryerson University, received a two-month sanction for an anti-doping rule violation. The athlete’s urine sample, collected during in-competition doping control on February 2, 2017, revealed the presence of cannabis.
The presence of cannabis, classified as a “specified substance” on the 2017 Prohibited List, is considered an adverse analytical finding when the urinary concentration exceeds 150 ng/mL. Under the rules of the Canadian Anti-Doping Program (CADP), an athlete facing a first violation involving a “specified substance” can seek to have the sanction reduced to a reprimand. Based on CCES’ assessment of the athlete’s degree of fault, the CCES proposed a two-month period of ineligibility.
In response to the CCES’ notification of the adverse analytical finding, Mr. Figliomeni admitted the violation in a timely fashion (in accordance with CADP Rule 10.11.2), waived his right to a hearing and accepted a sanction of two months ineligibility from sport (which terminated on April 10, 2017). The athlete, who resides in Toronto, Ontario, was ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates, during the sanction period. In compliance with rule 7.10 of the CADP, a copy of the CCES’ file summary can be found at www.cces.ca/canadian-sport-sanction-registry.
• This media release was originally published by the Canadian Centre for Ethics in Sport (CCES) on 25 April 2017. To access the original, please click here.
All Canadians deserve to participate and compete in a sport environment, free from harassment, abuse...
Leaders from 17 leading National Anti-Doping Organisations (NADOs), and iNADO (Institute of National Anti-Doping Organisations),...